Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people begin to notice the effects of Mounjaro within the first one to four weeks of starting treatment — though what those effects feel like, and how strong they are, changes considerably as the weeks go on. The first signs are often reduced hunger rather than visible weight loss. Mounjaro (tirzepatide) is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture yourself three days after your first injection. The pen arrived in a plain DPD box with a tracking notification, went straight into the fridge door, and now the effects you were expecting (dramatic appetite loss, a number plummeting on the scales) haven't quite materialised. That's normal, and it doesn't mean the medicine isn't working.
Tirzepatide activates two gut-hormone receptors, GIP and GLP-1, which together slow how quickly your stomach empties and signal fullness to the brain. Those processes start as soon as the medicine enters your system, but the effects at 2.5mg are deliberately gentle. You might notice you feel satisfied after less food, or that the pull towards a second portion just isn't there. Some people describe a slight decrease in how much food occupies their thoughts. These are real physiological changes — they're just not dramatic ones yet.
What can be more noticeable early on is how the medicine feels rather than how it works: mild nausea, some bloating, or a sense of sluggishness are common in the first week or two. The NHS tirzepatide patient information page lists these gastrointestinal effects as the most frequently reported, and most people find they ease within days to two weeks as the body adjusts. Starting slowly, eating smaller meals and staying well hydrated all help.
The four-week mark often brings the first dose increase (from 2.5mg to 5mg) and for many people this is when things genuinely shift. Appetite suppression becomes more consistent. Meals feel filling sooner, and the gap between meals gets longer without the usual hunger signals asserting themselves. If you're curious about when you start feeling the effects of Mounjaro, this period is often the turning point most people reflect on. This is also usually when the scales start to move more noticeably.
Clinical trial data gives a useful benchmark. In the SURMOUNT-1 trial, involving thousands of adults with obesity, participants at higher tirzepatide doses saw average body-weight reductions of around 20–21% over 72 weeks, but that figure accumulated over the full period, with dose increases happening step by step. The early weeks contribute less to the headline number. You can read more about what Mounjaro's effects look like across the full treatment period if you want the longer picture.
Side effects often settle significantly by this stage. Nausea that felt persistent in week one tends to become occasional (or disappears) by week six or eight for most people. That said, each dose step can briefly reset the GI adjustment process, so a fresh wave of mild symptoms after increasing from 5mg to 7.5mg, say, is not unusual. It usually passes faster than it did at the start.
Two people starting on the same day, at the same dose, can have noticeably different experiences of when they feel the effects of Mounjaro, with several factors shaping that gap. Metabolic rate, how much body water shifts early in treatment, starting body weight, diet composition alongside treatment, activity level and individual sensitivity to GLP-1 receptor agonists all play a role.
There is also a simple practical factor: adherence to the injection day. Tirzepatide is a once-weekly injection, and the drug level in the bloodstream reaches a steady state over several weeks. Irregular timing disrupts that steady state, which can blunt the appetite effect in unpredictable ways. Keeping to the same day each week matters more than many people expect.
If you are thinking about how this timeline fits your own situation, the tirzepatide overview covers the mechanism and the dosing schedule in more detail. For questions specific to your health history (particularly if you have a condition that affects gut motility or you take other medicines) a prescriber is the right person to ask. Our frequently asked questions page covers some of the most common queries we hear.
It is also worth knowing that the slower you titrate, the gentler the side-effect profile tends to be, but the longer the therapeutic effect takes to fully establish itself. That trade-off is not something to manage alone. Prescribers at nume review every repeat order before it is dispensed, so questions about timing can be addressed at each stage rather than left to guess-work. Private treatment through a regulated weight-loss service means that clinical oversight is built in, not bolted on.
Most of what you feel in the early weeks of Mounjaro is predictable and temporary. But some symptoms warrant prompt attention rather than patience. Severe stomach pain (particularly pain that radiates toward the back and does not ease) should never be waited out; seek urgent medical help and mention that you are taking tirzepatide. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but potentially serious effect of GLP-1 medicines, and reinforcing the importance of prompt assessment for that specific symptom. You can report any suspected side effects via the MHRA Yellow Card scheme.
Signs of dehydration from persistent vomiting or diarrhoea, symptoms of a severe allergic reaction, or any side effects that feel significant rather than mild warrant a call to your prescriber or, if urgent, 111 or 999. The side-effect profile is well-established, the more serious effects of Mounjaro and when to act on them are covered in full on a dedicated page. The treatment is not a passive process; staying in contact with your prescribing team is part of how it works safely.
For those considering starting treatment, the cost context is worth understanding alongside the clinical picture. Our Mounjaro price comparison guide explains what legitimate private pricing typically includes and what to watch out for. When you're ready to take the next step, start your free consultation and a named prescriber (not a form-processing algorithm) will review your answers the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.